Core Viewpoint - The study highlights the role of compartmentalized branched-chain amino acid (BCAA) metabolism in regulating the dissemination of colorectal cancer (CRC) through the UMP-vimentin signaling axis, suggesting that dietary restriction of BCAAs or inhibition of UMP biosynthesis can suppress CRC metastasis [3][6][7]. Group 1: Research Findings - Compartmentalized BCAA metabolism is identified as a pan-cancer biomarker for epithelial-mesenchymal transition (EMT) and cancer prognosis [7]. - The study demonstrates that cytoplasmic BCAA transaminase (BCAT) promotes EMT and accelerates tumor spread, while mitochondrial isoenzymes exhibit inhibitory effects [5][6]. - UMP derived from BCAAs stabilizes vimentin, facilitating CRC dissemination [6][7]. Group 2: Mechanistic Insights - The mechanism involves directing nitrogen flow from BCAAs to glutamate, aspartate, and UMP in the cytoplasm, while mitochondrial BCAT activity converts nitrogen flow to ammonia [6]. - Dietary restriction of BCAAs or blocking UMP biosynthesis effectively inhibits the spread of CRC with high BCAT1 expression, indicating the clinical relevance of BCAA metabolic compartmentalization in cancer metastasis [6][7].